Category Archives: Stem Cell Research

Read Time: Since Yamanakas demonstration in 2006 that adult cells can be reprogrammed to an embryonic stem cell-like state using a specific cocktail of transcription factors, interest in the development and use of induced pluripotent stem cells (iPSC) has flourished. Continue reading →

Parkinsons disease researchers have used gene-editing tools to introduce the disorders most common genetic mutation into marmoset monkey stem cells and to successfully tamp down cellular chemistry that often goes awry in Parkinsons patients. The edited cells are a step toward studying the degenerative neurological disorder in a primate model, which has proven elusive. Parkinsons, which affects more than 10 million people worldwide, progressively degrades the nervous system, causing characteristic tremors, dangerous loss of muscle control, cardiac and gastrointestinal dysfunction and other issues Continue reading →

TORRANCE, Calif.--(BUSINESS WIRE)--Celprogen Inc., a global leader in the Stem Cell Research and Therapeutics industry for stem cell research since 2002, today announced that they have been awarded the ISO 9001-2015 Certification; the internationally recognized standards to ensures that our products and services meet the needs of our global clients through an effective quality management system. Celprogen has developed and implemented their quality management system in order to improve the overall performance, maintain a high level of quality and strong customer service and to provide a sound basis for sustainable drug development initiatives as tested in their 3D human organ modeling systems, which includes the following major human organs: heart, brain, liver, kidney, pancreas, hair follicle and skin. The present inventions related to 3D organ printing programs at Celprogen identifies potential future uses in transplant of major organ systems Continue reading →

ORLANDO, Florida Chimeric antigen receptor (CAR) T-cell therapy can be safely delivered in the outpatient setting, which could make the life-extending treatment available to patients who don't have access to a major teaching hospital or treatment center, contend investigators who analyzed data from three clinical trials. Looking at outcomes for patients with large B-cell lymphomas (LBCL) who were treated with the CAR T-cell construct lisocabtagene maraleucel (liso-cel) in the outpatient setting at both university-based and nonacademic medical centers in three clinical trials, Carlos Bachier, MD, from the Sarah Cannon Blood Cancer Network in Nashville, Tennessee, and colleagues found that the incidences of severe adverse events were relatively low and manageable. "Outpatient administration of liso-cel and subsequent monitoring were successfully implemented in multiple clinical trials at both university and nonuniversity sites," he said here at the Transplantation and Cellular Therapy annual meeting. Continue reading →

February 28, 2020 11:55 ET | Source: Everest Foundation Los Angeles, Feb. 28, 2020 (GLOBE NEWSWIRE) -- Dr. Michael Everest through his foundation Everest Foundation is strengthening medical institutions by allocating to them millions of dollars each year to help with effectuating ground-breaking research in stem cell technology, nanotechnology, spinal injuries, and other areas Continue reading →

coverage of launch from Cape Canaveral Air Force Station will air on Space Coast Daily TV SpaceXs Dragon lifting off on a Falcon 9 rocket from Space Launch Complex 40 at Cape Canaveral Air Force Station in Florida with research, equipment, cargo and supplies that will support dozens of investigations aboard the International Space Station. (SpaceX image) BREVARD COUNTY CAPE CANAVERAL AIR FORCE STATION, FLORIDA NASA commercial cargo provider SpaceX is targeting 11:50 p.m Continue reading →

TMRR in its latest research report states that the global market size of Induced Pluripotent Stem Cells market was $XX million in 2018 with XX CAGR from 2014 to 2018, and is expected to reach $XX million by the end of 2029 with a CAGR of XX% from 2019 to 2029. Global Induced Pluripotent Stem Cells Market Report 2019 Market Size, Share, Price, Trend and Forecast is an intuitive and exhaustive study on the current and future prospects of the global Induced Pluripotent Stem Cells industry Continue reading →

As per a report Market-research, the Rheumatoid Arthritis Stem Cell Therapy economy is likely to see a CAGR increase of XX% within the forecast period (2019-2029) and reach at a value of US$ at the ending of 2029. The macro economic and micro elements which are predicted to influence the trajectory of this market are examined from the market analysis that was presented. Light onto the material throws Providers, vendors, manufacturers, and market participants at the value string of their industry that is Rheumatoid Arthritis Stem Cell Therapy Continue reading →

Stem Cell Therapy for Osteoarthritis Market report 2018, discusses various factors driving or restraining the market, which will help the future market to grow with promising CAGR. The Stem Cell Therapy for Osteoarthritis Market research Reports offers an extensive collection of reports on different markets covering crucial details. The report studies the competitive environment of the Stem Cell Therapy for Osteoarthritis Market is based on company profiles and their efforts on increasing product value and production Continue reading →

Medical treatment involving stem cells is an ever-growing, billion-dollar industry, so chances are you have heard about it in the news. Here in the U.S Continue reading →